Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 163521-12-8
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15DAY
Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram
Supply Ability: G,KG,TON
Appearance:: |
Light Yellow Solid |
CAS NO:: |
163521-12-8 |
Molecular Formula:: |
C26H28ClN5O2 |
Molecular Weight:: |
477.98600 |
EINECS NO:: |
NA |
MDL NO:: |
MFCD09838919 |
Appearance:: |
Light Yellow Solid |
CAS NO:: |
163521-12-8 |
Molecular Formula:: |
C26H28ClN5O2 |
Molecular Weight:: |
477.98600 |
EINECS NO:: |
NA |
MDL NO:: |
MFCD09838919 |
Product Description:
Product Name: VILAZODONE CAS NO: 163521-12-8
Synonyms:
5-[4-[4-(5-cyano-1-H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide;
2-BenzofurancarboxaMide,5-[4-[4-(5-cyano-1-H-indol-3-yl)butyl]-1-piperazinyl]-;
Vilazodonei;Vilazodone5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide;
Chemical & Physical Properties:
Appearance: Light yellow solid
Assay :≥98.00%
Density: 1.34 g/cm3
Boiling Point: 745.1℃ at 760 mmHg
Melting Point: 203-205℃
Storage Temp.: Refrigerator
Vilazodone is a kind of serotonergic antidepressant developed by Merck KGaA Company. It is a novel compound with high affinity and selectivity for the 5-hydroxytrptamine (5-HT) transporter and 5-HT (1A) receptors. It is indicated for the treatment of major depressive disorder (MDD). It is can be used as an alternative drugs for other kind of antidepressant classes drugs that can’t be tolerated by patients. As a selective serotonin reuptake inhibitor, vilazodone can prevent the serotonin from re-entering into cell bodies, therefore making it remain longer inside the synapse. Moreover, it has a high selectivity for the serotonin-1A receptor, taking effect as a partial agonist that can simulate the production of serotonin. These effects result in increased serotonin in the synaptic cleft. This effect is related to the antidepressant effect of vilazodone in vivo. It is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.